Pulmotil AC
INDICATIONS
- For the control of swine respiratory disease associated with Pasteurella multocida and Haemophilus parasuis.
- For the control of swine respiratory disease associated with Mycoplasma hyopneumoniae in the presence of porcine reproductive and respiratory syndrome virus (PRRSv) in groups of swine in buildings where a respiratory disease outbreak is diagnosed.
DOSAGE AND ADMINISTRATION
- Must be diluted before administration to animals.
- Include in the drinking water to provide a concentration of 200 mg tilmicosin per liter (200 ppm)
- One 960 ml bottle is sufficient to medicate 1200 liters (320 gallons) of drinking water for pigs.
- The medicated water should be administered for (5) five consecutive days.
- Use within 24 hours of mixing with water.
- Do not use rusty containers for medicated water as they may affect product integrity.
- When using a water medicating pump with a 1:128 inclusion rate, add 1 bottle (960 ml) of Pulmotil AC per 2.5 gallons of stock solution.
IMPORTANT SAFETY INFORMATION
See label for complete safety and use information, including boxed human warning. Before using this product, it is important to read the entire product insert, including the boxed human warning.
WARNING:Exposure to tilmicosin in humans has been associated with chest pain, increased heart rate, dizziness, headache, and nausea. Death has been reported following ingestion or injection of tilmicosin. Avoid direct skin and eye contact. In case of human exposure, call 1-800-722-0987 and consult a physician immediately.
- Wear overalls, impervious gloves and eye protection when mixing and handling the product. Wash hands after handling the product. Wash affected parts if skin contact occurs. If accidental eye contact occurs, immediately rinse thoroughly with water.
- CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- For use only in swine. Not for injection. Injection of tilmicosin has been shown to be fatal in swine and nonhuman primates, and may be fatal in horses and goats.
- Swine intended for human consumption must not be slaughtered within 7 days of treatment.
- Always treat the fewest number of animals necessary to control a respiratory disease outbreak. Prescriptions shall not be refilled.
- Concurrent use of Pulmotil AC and another macrolide by any route, or use of another macrolide immediately following this use of Pulmotil AC is not advised.
- Ensure that pigs have continuous access to medicated water during the treatment period. Monitor pigs for signs of water refusal and dehydration while being treated.
Baytril 100
INDICATIONS
- For the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Glaesserella parasuis (Haemophilus parasuis), Streptococcus suis, Bordetella bronchiseptica, Mycoplasma hyopneumoniae and Escherichia coli.
- For the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with Escherichia coli has been diagnosed.
DOSAGE AND ADMINISTRATION
- Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100lb). Administered dose volume should not exceed 5 mL per injection site.
- For the control of colibacillosis, administration should be initiated within the first 60 days post-weaning when clinical signs are present in at least 2% of the animals in the group. If no improvement is noted within 48 hours, the diagnosis should be re-evaluated.
IMPORTANT SAFETY INFORMATION
CAUTIONFederal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food producing animals. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options.
- Not for use in humans. Keep out of reach of children.
- Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes.
- In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposures.
- Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.
Increxxa – tulathromycin Injection
INDICATIONS
- Indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae.
- Indicated for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.
DIRECTIONS FOR USE
- Inject intramuscularly as a single dose in the neck at a dosage of 2.5 mg/kg (0.25 mL/ 22 lb) body weight (BW). Do not inject more than 2.5 mL per injection site.
INFORMATION SAFETY INFORMATION
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
- WARNINGS: FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. NOT FOR USE IN CHICKENS OR TURKEYS.
- Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.
- The effects of Increxxa on porcine reproductive performance, pregnancy, and lactation have not been determined.
- Intramuscular injection can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.
- Store below 25°C (77°F), with excursions up to 40°C (104°F).
- 100 mL: Use within 2 months of first puncture and puncture a maximum of 67 times. If more than 67 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
- 250 mL and 500 mL: Use within 2 months of first puncture and puncture a maximum of 100 times. If more than 100 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
Tylan Soluble
INDICATIONS
- For the treatment and control of swine dysentery (SD) associated with Brachyspira hyodysenteriae.
- For the treatment and control of SD associated with Brachyspira hyodysenteriae when followed immediately by Tylan Type A medicated article in feed.
- For the control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis when followed by Tylan Type A medicated article in feed.
DIRECTIONS FOR USE
- Dosage for swine: 250 mg/gallon (66 ppm) in drinking water.
- Always add the water to the powder. Do not pour the powder into the water. Prepare a fresh Tylan Soluble solution every three days. When mixing and handling tylosin, use protective clothing and impervious gloves.
- For swine dysentery, administer medicated drinking water for 3 to 10 days, depending upon severity of infection. Alternatively, administer medicated drinking water for 3 to 10 days, followed by 40 to 100 g tylosin per ton of complete feed (Type C medicated feed manufactured from Tylan Type A medicated article) for 2 to 6 weeks.
- For PPE, administer medicated drinking water for 3 to 10 days, followed by 40 to 100 g of tylosin per ton of complete feed (Type C medicated feed manufactured from Tylan A medicated article) for 2 to 6 weeks.
- Only medicated water should be available to swine while medicating with Tylan Soluble.
IMPORTANT SAFETY INFORMATION
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
- Not for human use. Keep out of reach of children. Avoid contact with skin. Exposure to tylosin may cause a rash.
- Swine must not be slaughtered for food within 48 hours after treatment.
